Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease

OBJECTIVES: Ferumoxytol is an alternative to gadolinium-based compounds as a vascular contrast agent for magnetic resonance angiography (MRA), particularly for patients with chronic kidney disease (CKD). However, dose-related efficacy data are lacking. We aimed to determine the optimal (minimum effe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur Radiol
Hlavní autoři: Stoumpos, Sokratis, Hennessy, Martin, Vesey, Alex T., Radjenovic, Aleksandra, Kasthuri, Ram, Kingsmore, David B., Mark, Patrick B., Roditi, Giles
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Berlin Heidelberg 2019
Témata:
Magnetic Resonance
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554242/
https://ncbi.nlm.nih.gov/pubmed/30919067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00330-019-06137-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky